Methodist Home Health Certified | |
221 N.e. Glen Oak Ave. Mailing Address, Peoria, Illinois 61636 | |
(309) 671-8247 | |
Name | Methodist Home Health Certified |
---|---|
Location | 221 N.e. Glen Oak Ave. Mailing Address, Peoria, Illinois |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 147259 |
Ownership Type | Voluntary Non-profit - Private |
Service Area Zip Codes | 61369, 61375, 61421, 61424, 61427, 61432, 61433, 61441, 61451, 61459, 61483, 61489, 61491, 61501, 61517, 61520, 61523, 61525, 61526, 61528, 61529, 61530, 61531, 61532, 61533, 61534, 61535, 61536, 61537, 61539, 61540, 61541, 61542, 61544, 61545, 61546, 61547, 61548, 61550, 61554, 61559, 61561, 61562, 61563, 61564, 61565, 61567, 61568, 61569, 61570, 61571, 61572, 61602, 61603, 61604, 61605, 61606, 61607, 61610, 61611, 61614, 61615, 61616, 61636, 61733, 61734, 61742, 61747, 61755, 61759, 62644, 62682 |
NPI Number | 1821043365 |
Organization Name | METHODIST MEDICAL CENTER OF ILLINOIS |
Address | 221 Ne Glen Oak Ave, Peoria, IL 61636 |
Phone Number | 309-672-4887 |
News Archive
GE Healthcare today announced FDA clearance of the CARESCAPE™ Monitor B650, a flexible patient monitoring solution that supports efficient clinical decision-making. The CARESCAPE Monitor B650 improves data integration and connectivity by directly linking to the GE Healthcare CARESCAPE portfolio of monitoring products-including the latest bedside, central station and transport monitors-as well as existing GE Healthcare monitors and peripheral third-party devices.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that on February 1, 2011 the U.S. Patent and Trademark Office issued U.S. Patent No. 7,879,802, covering Synergy's novel drug candidate SP-333 to treat inflammatory bowel disease.
News-Medical speaks to Elisabeth Fassas about the process and struggles of getting into medical school, in which she has recently published in her book, Making Pre-Med Count.
A new biodegradable material which could help regenerate spinal cord tissue without invasive surgery is being developed by Monash University PhD student, Ms Rosalyn Jackson.
› Verified 6 days ago
Quality Rating: |
News Archive
GE Healthcare today announced FDA clearance of the CARESCAPE™ Monitor B650, a flexible patient monitoring solution that supports efficient clinical decision-making. The CARESCAPE Monitor B650 improves data integration and connectivity by directly linking to the GE Healthcare CARESCAPE portfolio of monitoring products-including the latest bedside, central station and transport monitors-as well as existing GE Healthcare monitors and peripheral third-party devices.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that on February 1, 2011 the U.S. Patent and Trademark Office issued U.S. Patent No. 7,879,802, covering Synergy's novel drug candidate SP-333 to treat inflammatory bowel disease.
News-Medical speaks to Elisabeth Fassas about the process and struggles of getting into medical school, in which she has recently published in her book, Making Pre-Med Count.
A new biodegradable material which could help regenerate spinal cord tissue without invasive surgery is being developed by Monash University PhD student, Ms Rosalyn Jackson.
› Verified 6 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 97.8 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 99.8 | 98.6 |
How often the home health team checked patients’ risk of falling | 99.6 | 99.6 |
How often the home health team checked patients for depression | 99.5 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 78.8 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 89 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 99.5 | 96.4 |
News Archive
GE Healthcare today announced FDA clearance of the CARESCAPE™ Monitor B650, a flexible patient monitoring solution that supports efficient clinical decision-making. The CARESCAPE Monitor B650 improves data integration and connectivity by directly linking to the GE Healthcare CARESCAPE portfolio of monitoring products-including the latest bedside, central station and transport monitors-as well as existing GE Healthcare monitors and peripheral third-party devices.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that on February 1, 2011 the U.S. Patent and Trademark Office issued U.S. Patent No. 7,879,802, covering Synergy's novel drug candidate SP-333 to treat inflammatory bowel disease.
News-Medical speaks to Elisabeth Fassas about the process and struggles of getting into medical school, in which she has recently published in her book, Making Pre-Med Count.
A new biodegradable material which could help regenerate spinal cord tissue without invasive surgery is being developed by Monash University PhD student, Ms Rosalyn Jackson.
› Verified 6 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 77 | 79.6 |
How often patients got better at getting in and out of bed | 78.7 | 81.1 |
How often patients got better at bathing | 74.4 | 82.3 |
How often patients’ breathing improved | 83.1 | 82.8 |
How often patients’ wounds improved or healed after an operation | 91.5 | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 68.7 | 75 |
How often home health patients had to be admitted to the hospital | 17.6 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 13.9 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 97.6 | 94 |
News Archive
GE Healthcare today announced FDA clearance of the CARESCAPE™ Monitor B650, a flexible patient monitoring solution that supports efficient clinical decision-making. The CARESCAPE Monitor B650 improves data integration and connectivity by directly linking to the GE Healthcare CARESCAPE portfolio of monitoring products-including the latest bedside, central station and transport monitors-as well as existing GE Healthcare monitors and peripheral third-party devices.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that on February 1, 2011 the U.S. Patent and Trademark Office issued U.S. Patent No. 7,879,802, covering Synergy's novel drug candidate SP-333 to treat inflammatory bowel disease.
News-Medical speaks to Elisabeth Fassas about the process and struggles of getting into medical school, in which she has recently published in her book, Making Pre-Med Count.
A new biodegradable material which could help regenerate spinal cord tissue without invasive surgery is being developed by Monash University PhD student, Ms Rosalyn Jackson.
› Verified 6 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
GE Healthcare today announced FDA clearance of the CARESCAPE™ Monitor B650, a flexible patient monitoring solution that supports efficient clinical decision-making. The CARESCAPE Monitor B650 improves data integration and connectivity by directly linking to the GE Healthcare CARESCAPE portfolio of monitoring products-including the latest bedside, central station and transport monitors-as well as existing GE Healthcare monitors and peripheral third-party devices.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that on February 1, 2011 the U.S. Patent and Trademark Office issued U.S. Patent No. 7,879,802, covering Synergy's novel drug candidate SP-333 to treat inflammatory bowel disease.
News-Medical speaks to Elisabeth Fassas about the process and struggles of getting into medical school, in which she has recently published in her book, Making Pre-Med Count.
A new biodegradable material which could help regenerate spinal cord tissue without invasive surgery is being developed by Monash University PhD student, Ms Rosalyn Jackson.
› Verified 6 days ago
The patient survey data of Methodist Home Health Certified is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 88 | 88 |
Percent of patients who reported that their home health team communicated well with them | 88 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 83 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 87 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 82 | 78 |
News Archive
GE Healthcare today announced FDA clearance of the CARESCAPE™ Monitor B650, a flexible patient monitoring solution that supports efficient clinical decision-making. The CARESCAPE Monitor B650 improves data integration and connectivity by directly linking to the GE Healthcare CARESCAPE portfolio of monitoring products-including the latest bedside, central station and transport monitors-as well as existing GE Healthcare monitors and peripheral third-party devices.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that on February 1, 2011 the U.S. Patent and Trademark Office issued U.S. Patent No. 7,879,802, covering Synergy's novel drug candidate SP-333 to treat inflammatory bowel disease.
News-Medical speaks to Elisabeth Fassas about the process and struggles of getting into medical school, in which she has recently published in her book, Making Pre-Med Count.
A new biodegradable material which could help regenerate spinal cord tissue without invasive surgery is being developed by Monash University PhD student, Ms Rosalyn Jackson.
› Verified 6 days ago
St. Francis Medical Center Location: 2265 W Altorfer Dr, Peoria, Illinois 61615 Ratings: Phone: (309) 683-7700 | |
Methodist Home Health Certified Location: 221 N.e. Glen Oak Ave. Mailing Address, Peoria, Illinois 61636 Ratings: Phone: (309) 671-8247 |